A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine.
about
Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.The behavioral pharmacology of hallucinogensRecent advances in the neuropsychopharmacology of serotonergic hallucinogensIn Vitro and In Vivo Characterization of the Alkaloid NuciferinePsychedelicsAnimal models of tic disorders: a translational perspective.Animal models of serotonergic psychedelics.Photochemical activation of TRPA1 channels in neurons and animalsCharacterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement.Antidepressant-like effects of a water-soluble extract from the culture medium of Ganoderma lucidum mycelia in rats5-HT1A agonists: alcohol drinking in rats and squirrel monkeys.Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice.Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivoPharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonistTryptamines and spinal cord reflexes in cats.Effects of drugs affecting endogenous amines or cyclic nucleotides on ethanol withdrawal head twitches in mice.Research on acute toxicity and the behavioral effects of methanolic extract from psilocybin mushrooms and psilocin in miceIndoleamine antagonists: relative potencies as inhibitors of tryptamine- and 5-hydroxytryptophan-evoked responses.In vivo pharmacological studies on the interactions between tryptamine and 5-hydroxytryptamine.MDMA-like behavioral effects of N-substituted piperazines in the mouse.Food restriction and streptozotocin treatment decrease 5-HT1A and 5-HT2A receptor-mediated behavioral effects in rats.Directly Observable Behavioral Effects of Lorcaserin in RatsHallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents.Serotonin receptor signaling and regulation via β-arrestins.Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degenerationGaddum and LSD: the birth and growth of experimental and clinical neuropharmacology research on 5-HT in the UKCodeine and its alternates for pain and cough relief. I. Codeine, exclusive of its antitussive action.In vitro, in vivo, and clinical studies of tedizolid to assess the potential for peripheral or central monoamine oxidase interactions.A CONTROLLED CLINICAL TRIAL OF ALPHA METHYL DOPA IN PARKINSONIAN TREMOR.Physiological and pharmacological implications of beta-arrestin regulation.Restricted access to standard or high fat chow alters sensitivity of rats to the 5-HT(2A/2C) receptor agonist 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane.Antidepressant Effects of Mallotus oppositifolius in Acute Murine Models.Effect of cortisol on a central response to 5-hydroxytryptophan.Functional changes in cerebral 5-hydroxytryptamine metabolism in the mouse induced by anticonvulsant drugs.The 'wet dog shake" behaviour in the rat and 5-hydroxytryptamine [proceedings].CENTRAL STIMULANT ACTIONS OF ALPHA-ALKYL SUBSTITUTED TRYPTAMINES IN MICE.Synthesis, central nervous system activity, and structure-activity relationship of 1-aryl-6-benzyl-7-hydroxy-2,3-dihydroimidazo[1,2-a]pyrimidine-5(1H)-ones.Antidepressant treatments: effects in rodents on dose-response curves of 5-hydroxytryptamine- and dopamine-mediated behaviours and 5-HT2 receptor number in frontal cortex.Modulation of 5-hydroxytryptamine-induced head-twitch response by drugs acting at GABA and related receptors.
P2860
Q24595389-2E9914AD-85DE-4DA8-A1A9-D7DB8145A3D7Q24620764-7725FEDC-D3B1-4BD1-843F-19CA6FE3C063Q24645656-1A53F8FB-EE72-4483-8800-B9E13C770C99Q27027381-80F1EB0F-E169-40F5-9310-3B3BC1AD7B38Q28550683-A4C4CD72-9289-4AE2-B2BD-970EB17F7A8CQ30359998-D8B36BBF-0109-4D99-AC80-174BC874B00EQ30395243-710C65B4-1612-4EE7-95E9-91A9A9D9C46BQ30444312-EFEB25A2-A4C3-4EB9-9596-FD44FF17EB11Q30537874-DB87AB29-6CC7-4A0E-ADBB-52D0F5FE0AA8Q30559794-C86EB302-F43F-4CAE-9C5D-7CC0145ED3B9Q31146713-DCFB9EDB-AB48-415D-9956-40392B502DE3Q34186220-54C83CC6-C3D6-41CA-B2FC-2DD404BEBE22Q34359895-BA8FA64D-A40C-4A89-9B96-4B5698CAA8F8Q34402623-35E240E0-F20D-4D7D-AB5F-C7B97C9A5FC8Q34427738-B7847EC1-4472-49D0-898C-23E53C3BCBA4Q35011736-9D361E5B-8B3C-44C3-92D8-0FC5BA255591Q35176148-F9AE9F3E-5304-4EBC-B05A-D07BE20BF39AQ35564012-EE1468B8-399A-40DD-819A-6B37D5D0D024Q35600962-CC9A609F-581E-409A-9BAE-76411E42CD7BQ36128235-2604274D-21E2-48A5-BF1A-7110E4EC432CQ36151338-A6277BA7-98E1-4F9B-8870-01B6EE3024E3Q36297068-EC4A84B3-4174-4FBE-A643-97C5162A1C0EQ36316458-FD59C09F-B5EE-44D9-982D-BD7CFD36C9DCQ36569714-DF251EAB-28B3-4B6A-B416-3CD61194ED74Q36647024-7F2A6477-5462-4FA4-9FC9-B4C6D0BBD555Q36691830-01C62B26-0C56-4158-8294-3AC65B2B264FQ36842508-6F9AE717-9B7C-449A-8579-5195FEF6BBEEQ36911686-B69ED00E-29CB-44AF-B68F-EF6737FBA90DQ36969769-695B0D59-1E15-44F7-B6E4-574DC015DE9CQ37115478-3B02F291-C669-4114-84F3-D008C93A05B5Q37356068-98572367-53D3-4B38-8E3D-2F63A5926AD2Q37619179-E2D21E0C-23D8-485F-B09C-1AA0278A63C6Q38591030-154BB0FA-58C5-4D17-9382-BA2F9F2477E1Q39995916-EA649B93-24CF-468A-87F8-923A764E7F81Q40034055-717FA0ED-DEBD-4BDD-A33D-110669CF4BFFQ40038459-B327AEAE-C855-4E52-BD4B-067C5A82B054Q41409984-D5A6C160-F756-405A-943C-8051FA692DE2Q41828638-FA3ECCD7-8373-4210-8E79-7FD6BBF224E9Q41911724-252DC35B-2DD2-42DB-BAEB-B519DF947D12Q42572825-A2F7ABAB-F3A9-4644-A2DF-41783BF3B983
P2860
A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine.
description
1963 nî lūn-bûn
@nan
1963 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1963 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1963年の論文
@ja
1963年論文
@yue
1963年論文
@zh-hant
1963年論文
@zh-hk
1963年論文
@zh-mo
1963年論文
@zh-tw
1963年论文
@wuu
name
A method for assessing the eff ...... ctions of 5-hydroxytryptamine.
@ast
A method for assessing the eff ...... ctions of 5-hydroxytryptamine.
@en
type
label
A method for assessing the eff ...... ctions of 5-hydroxytryptamine.
@ast
A method for assessing the eff ...... ctions of 5-hydroxytryptamine.
@en
prefLabel
A method for assessing the eff ...... ctions of 5-hydroxytryptamine.
@ast
A method for assessing the eff ...... ctions of 5-hydroxytryptamine.
@en
P2093
P2860
P1476
A method for assessing the eff ...... ctions of 5-hydroxytryptamine.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1963.TB01302.X
P407
P577
1963-02-01T00:00:00Z